title: Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease.
abstract: RBCs from individuals with sickle cell disease are more susceptible to oxidant damage. Because key antioxidant defense reactions are linked to the pyridine nucleotides nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), we tested the hypothesis that the RBC redox potential as manifested by the NADH/[NAD+ + NADH] and NADPH/[NADP+ + NADPH] ratios is decreased in sickle erythrocytes. Our data demonstrate that sickle RBCs have a significant decrease in the NADH/[NAD+ + NADH] ratio compared with normal RBCs (P less than .00005). Interestingly, sickle RBCs also had a significant increase in total NAD content compared with normal RBCs (P less than .00005). In contrast, although sickle RBCs had a significant increase in the total NADP content compared with normal RBCs (P less than .00005), sickle RBCs had no significant alteration in the NADPH/[NADP+ + NADPH] ratio. High reticulocyte controls demonstrated that these changes were not related to cell age. Thus, sickle RBCs have a decrease in NAD redox potential that may be a reflection of their increased oxidant sensitivity. The changes in these pyridine nucleotides may have further metabolic consequences for the sickle erythrocyte.
authors.affiliation: Department of Medicine, Harbor-UCLA Medical Center, University of California at Los Angeles School of Medicine, Torrance 90502.
authors.forename: C R
authors.initials: CR
authors.lastname: Zerez
authors.forename: N A
authors.initials: NA
authors.lastname: Lachant
authors.forename: S J
authors.initials: SJ
authors.lastname: Lee
authors.forename: K R
authors.initials: KR
authors.lastname: Tanaka
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood* / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D009243:NAD / Q000097:blood*; D009249:NADP / Q000097:blood*; D010084:Oxidation-Reduction
chemical_list: D009243:NAD; D009249:NADP